Tags

Type your tag names separated by a space and hit enter

Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.
J Clin Microbiol. 2020 Jul 23; 58(8)JC

Links

Publisher Full Text
ncbi.nlm.nih.gov
jcm.asm.org
PMC Free PDF

Authors+Show Affiliations

Broder K
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Babiker A
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Myers C
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
White T
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Jones H
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Cardella J
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Burd EM
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Hill CE
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Kraft CS
Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA colleen.kraft@emory.edu. Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA.

MeSH

BetacoronavirusCOVID-19COVID-19 TestingClinical Laboratory TechniquesCoronavirus InfectionsHumansMolecular Diagnostic TechniquesNasopharynxNucleic Acid Amplification TechniquesPandemicsPneumonia, ViralSARS-CoV-2

Pub Type(s)

Comparative Study
Evaluation Study
Letter

Language

eng

PubMed ID

32444354

Citation

Broder, Kari, et al. "Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges." Journal of Clinical Microbiology, vol. 58, no. 8, 2020.
Broder K, Babiker A, Myers C, et al. Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges. J Clin Microbiol. 2020;58(8).
Broder, K., Babiker, A., Myers, C., White, T., Jones, H., Cardella, J., Burd, E. M., Hill, C. E., & Kraft, C. S. (2020). Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges. Journal of Clinical Microbiology, 58(8). https://doi.org/10.1128/JCM.01187-20
Broder K, et al. Test Agreement Between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges. J Clin Microbiol. 2020 Jul 23;58(8) PubMed PMID: 32444354.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges. AU - Broder,Kari, AU - Babiker,Ahmed, AU - Myers,Charles, AU - White,Terri, AU - Jones,Heather, AU - Cardella,John, AU - Burd,Eileen M, AU - Hill,Charles E, AU - Kraft,Colleen S, Y1 - 2020/07/23/ PY - 2020/5/24/pubmed PY - 2020/8/5/medline PY - 2020/5/24/entrez KW - COVID-19 KW - RT-PCR KW - SARS-CoV-2 KW - diagnostics KW - virology JF - Journal of clinical microbiology JO - J Clin Microbiol VL - 58 IS - 8 SN - 1098-660X UR - https://www.unboundmedicine.com/medline/citation/32444354/Test_Agreement_between_Roche_Cobas_6800_and_Cepheid_GeneXpert_Xpress_SARS_CoV_2_Assays_at_High_Cycle_Threshold_Ranges_ L2 - http://jcm.asm.org/cgi/pmidlookup?view=long&pmid=32444354 DB - PRIME DP - Unbound Medicine ER -